Literature DB >> 20238482

[Type and extent of preoperative imaging before radical prostatectomy].

H Isbarn1, S Kellermann, G Salomon, T Steuber, H Huland, M Graefen.   

Abstract

BACKGROUND: According to current guidelines, in cases of newly diagnosed prostate cancer the type and extent of imaging to be performed should be based on the patient's risk profile. We investigated the rate of computed tomography (CT), magnetic resonance imaging (MRI), and bone scintigraphy carried out before radical prostatectomy (RP) depending on the individual risk profile. PATIENTS AND
METHOD: Between 1 January 2006 and 31 December 2007, a total of 1,018 consecutive patients who had not received neoadjuvant hormone therapy were treated with RP in our department. We determined the preoperative rates of CT, MRI, and bone scintigraphy by reviewing the medical charts. The patients were stratified according to the D'Amico criteria into low-risk, intermediate-risk, and high-risk groups.
RESULTS: Of the 1,018 subjects, 493 (48%) were classified as low-risk, 403 (40%) as intermediate-risk, and 122 (12%) as high-risk patients, respectively. The rate of preoperative abdominal CT/MRI and bone scintigraphy was 17 and 23% in the low-risk group, 25 and 39% in the intermediate-risk patients, and 39 and 57% in the high-risk group.
CONCLUSION: The rate of preoperative CT and bone scintigraphy is extremely high in the low-risk group. In contrast the rate in the high-risk patients more likely appears to be too low. The discrepancy between the rates of preoperative imaging subject to the patient's risk profile shows that precisely formulated guidelines addressing this issue are needed.

Entities:  

Mesh:

Year:  2010        PMID: 20238482     DOI: 10.1007/s00120-009-2207-x

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  11 in total

1.  Open retropubic nerve-sparing radical prostatectomy.

Authors:  Markus Graefen; Jochen Walz; Hartwig Huland
Journal:  Eur Urol       Date:  2005-11-18       Impact factor: 20.096

2.  Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy.

Authors:  Thomas Steuber; Markus Graefen; Alexander Haese; Andreas Erbersdobler; Felix K-H Chun; Thorsten Schlom; Paul Perrotte; Hartwig Huland; Pierre I Karakiewicz
Journal:  J Urol       Date:  2006-03       Impact factor: 7.450

3.  Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy.

Authors:  Alberto Briganti; Felix K-H Chun; Andrea Salonia; Giuseppe Zanni; Vincenzo Scattoni; Luc Valiquette; Patrizio Rigatti; Francesco Montorsi; Pierre I Karakiewicz
Journal:  Eur Urol       Date:  2006-02-17       Impact factor: 20.096

4.  Guideline for the management of clinically localized prostate cancer: 2007 update.

Authors:  Ian Thompson; James Brantley Thrasher; Gunnar Aus; Arthur L Burnett; Edith D Canby-Hagino; Michael S Cookson; Anthony V D'Amico; Roger R Dmochowski; David T Eton; Jeffrey D Forman; S Larry Goldenberg; Javier Hernandez; Celestia S Higano; Stephen R Kraus; Judd W Moul; Catherine M Tangen
Journal:  J Urol       Date:  2007-06       Impact factor: 7.450

Review 5.  EAU guidelines on prostate cancer.

Authors:  Axel Heidenreich; Gunnar Aus; Michel Bolla; Steven Joniau; Vsevolod B Matveev; Hans Peter Schmid; Filliberto Zattoni
Journal:  Eur Urol       Date:  2007-09-19       Impact factor: 20.096

6.  Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.

Authors:  D F Gleason; G T Mellinger
Journal:  J Urol       Date:  1974-01       Impact factor: 7.450

7.  Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy.

Authors:  Andrea Gallina; Felix K-H Chun; Alberto Briganti; Shahrokh F Shariat; Francesco Montorsi; Andrea Salonia; Andreas Erbersdobler; Patrizio Rigatti; Luc Valiquette; Hartwig Huland; Markus Graefen; Pierre I Karakiewicz
Journal:  Eur Urol       Date:  2007-01-22       Impact factor: 20.096

8.  Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005.

Authors:  Danil V Makarov; Bruce J Trock; Elizabeth B Humphreys; Leslie A Mangold; Patrick C Walsh; Jonathan I Epstein; Alan W Partin
Journal:  Urology       Date:  2007-06       Impact factor: 2.649

Review 9.  New horizons in prostate cancer imaging.

Authors:  Gregory Ravizzini; Baris Turkbey; Karen Kurdziel; Peter L Choyke
Journal:  Eur J Radiol       Date:  2008-11-07       Impact factor: 3.528

10.  Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread.

Authors:  J E McNeal; E A Redwine; F S Freiha; T A Stamey
Journal:  Am J Surg Pathol       Date:  1988-12       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.